Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J N Wells

Showing results (61-70 of 69) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 69 results.
Journal of Cyclic Nucleotide and Protein Phosphorylation Research|January 1, 1986
Irreversible inhibition of calmodulin-sensitive cyclic nucleotide phosphodiesteraseT A Sullivan, B H Duemler, N J Kuttesch, et al.
Molecular Pharmacology|October 1, 1988
Relaxation of vascular and tracheal smooth muscle by cyclic nucleotide analogs that preferentially activate purified cGMP-dependent protein kinaseS H Francis, B D Noblett, B W Todd, et al.
The Journal of Biological Chemistry|October 5, 1988
Biochemical events associated with activation of smooth muscle contractionW C Miller-Hance, J R Miller, J N Wells, et al.
Biochemistry|February 26, 1985
Functional properties of covalent beta-endorphin peptide/calmodulin complexes. Chlorpromazine binding and phosphodiesterase activationD P Giedroc, T M Keravis, J V Staros, et al.
Biochemical Pharmacology|November 14, 2001
Inhibition of human mast cell activation with the novel selective adenosine A(2B) receptor antagonist 3-isobutyl-8-pyrrolidinoxanthine (IPDX)(2)I Feoktistov, E M Garland, A E Goldstein, et al.
Advances in Cyclic Nucleotide and Protein Phosphorylation Research|January 1, 1984
Negative regulation of cyclic AMP levels by activation of cyclic nucleotide phosphodiesterases: the example of the dog thyroidJ E Dumont, F Miot, C Erneux, et al.
Cell Biochemistry and Biophysics|June 19, 1998
A photoaffinity probe covalently modifies the catalytic site of the cGMP-binding cGMP-specific phosphodiesterase (PDE-5)J D Corbin, A Beasley, I V Turko, et al.
Molecular Pharmacology|July 1, 1992
Relaxation of pig coronary arteries by new and potent cGMP analogs that selectively activate type I alpha, compared with type I beta, cGMP-dependent protein kinaseK R Sekhar, R J Hatchett, J B Shabb, et al.
Advances in Second Messenger and Phosphoprotein Research|January 1, 1988
Mechanism and function of cAMP- and cGMP-dependent protein kinasesJ D Corbin, C E Cobb, S J Beebe, et al.
Pageof 7

Showing results (61-70 of 69) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 69 results.
Journal of Cyclic Nucleotide and Protein Phosphorylation Research|January 1, 1986
Irreversible inhibition of calmodulin-sensitive cyclic nucleotide phosphodiesteraseT A Sullivan, B H Duemler, N J Kuttesch, et al.
Molecular Pharmacology|October 1, 1988
Relaxation of vascular and tracheal smooth muscle by cyclic nucleotide analogs that preferentially activate purified cGMP-dependent protein kinaseS H Francis, B D Noblett, B W Todd, et al.
The Journal of Biological Chemistry|October 5, 1988
Biochemical events associated with activation of smooth muscle contractionW C Miller-Hance, J R Miller, J N Wells, et al.
Biochemistry|February 26, 1985
Functional properties of covalent beta-endorphin peptide/calmodulin complexes. Chlorpromazine binding and phosphodiesterase activationD P Giedroc, T M Keravis, J V Staros, et al.
Biochemical Pharmacology|November 14, 2001
Inhibition of human mast cell activation with the novel selective adenosine A(2B) receptor antagonist 3-isobutyl-8-pyrrolidinoxanthine (IPDX)(2)I Feoktistov, E M Garland, A E Goldstein, et al.
Advances in Cyclic Nucleotide and Protein Phosphorylation Research|January 1, 1984
Negative regulation of cyclic AMP levels by activation of cyclic nucleotide phosphodiesterases: the example of the dog thyroidJ E Dumont, F Miot, C Erneux, et al.
Cell Biochemistry and Biophysics|June 19, 1998
A photoaffinity probe covalently modifies the catalytic site of the cGMP-binding cGMP-specific phosphodiesterase (PDE-5)J D Corbin, A Beasley, I V Turko, et al.
Molecular Pharmacology|July 1, 1992
Relaxation of pig coronary arteries by new and potent cGMP analogs that selectively activate type I alpha, compared with type I beta, cGMP-dependent protein kinaseK R Sekhar, R J Hatchett, J B Shabb, et al.
Advances in Second Messenger and Phosphoprotein Research|January 1, 1988
Mechanism and function of cAMP- and cGMP-dependent protein kinasesJ D Corbin, C E Cobb, S J Beebe, et al.
Pageof 7